SPI
18.219,49
PKT
+34,44
PKT
+0,19
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.07.12 | Galenica reduce | Vontobel Research | |
| 20.07.12 | Dätwyler hold | Vontobel Research | |
| 20.07.12 | Clariant buy | Vontobel Research | |
| 20.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 20.07.12 | SGS SA buy | Vontobel Research | |
| 19.07.12 | Swisscom buy | Banc of America Securities-Merrill Lynch | |
| 19.07.12 | UBS overweight | J.P. Morgan Cazenove | |
| 19.07.12 | UBS hold | Deutsche Bank AG | |
| 19.07.12 | Novartis halten | Independent Research GmbH | |
| 19.07.12 | Novartis buy | Sarasin Research | |
| 19.07.12 | UBS underperform | Exane-BNP Paribas SA | |
| 19.07.12 | Swisscom neutral | Nomura | |
| 19.07.12 | ABB (Asea Brown Boveri) hold | ING | |
| 19.07.12 | Logitech hold | Vontobel Research | |
| 19.07.12 | UBS equal-weight | Morgan Stanley | |
| 19.07.12 | Clariant buy | Vontobel Research | |
| 19.07.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 19.07.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 19.07.12 | UBS hold | Vontobel Research | |
| 19.07.12 | UBS halten | Independent Research GmbH | |
| 18.07.12 | UBS buy | Citigroup Corp. | |
| 18.07.12 | UBS buy | Citigroup Corp. | |
| 18.07.12 | UBS neutral | Sarasin Research | |
| 18.07.12 | UBS hold | Commerzbank Corp. & Markets | |
| 18.07.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 18.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.07.12 | Zug Estates B hold | Vontobel Research | |
| 18.07.12 | SGS SA buy | Vontobel Research | |
| 18.07.12 | EMS-CHEMIE hold | Vontobel Research | |
| 18.07.12 | Helvetia Baloise neutral | Sarasin Research | |
| 17.07.12 | Novartis buy | Deutsche Bank AG | |
| 17.07.12 | Roche buy | Deutsche Bank AG | |
| 17.07.12 | Barry Callebaut neutral | Sarasin Research | |
| 17.07.12 | Kühne + Nagel International neutral | UBS AG | |
| 17.07.12 | Kühne + Nagel International buy | Nomura | |
| 17.07.12 | Novartis buy | Société Générale Group S.A. (SG) |